Risk assessment advisor comes to CVM

Rockville, Md.-The Food and Drug Administration's Center for VeterinaryMedicine (CVM) recently appointed an expert in public health to developan antimicrobial risk assessment policy.

H. Gregg Claycamp, Ph.D., CHP, joined CVM as the senior advisor for riskassessment. His mandate: develop antimicrobial risk assessment policy usingstate-of-the art science. Claycamp will also serve as the senior scientistfor CVM's Office of New Animal Drug Evaluation (ONADE) in all other riskassessment issues.

Claycamp comes to the agency from the University of Pittsburgh, GraduateSchool of Public Health, where he was a professor in the Department of Environmentaland Occupational Health. At the University of Pittsburgh, Claycamp directedthe graduate programs in the Risk Assessment and Radiation Health whilemaintaining an active research and teaching career.

His research has included international studies in radiation risk assessment,chemical hazard identification, environmental exposures and basic studieson radiation or chemically induced DNA damage in both microbes and animalcells.

Notable achievements have included novel applications of artificial intelligencefor diverse problems in human health risk assessment, CVM reports.